Renata PLC (DSE: RENATA)
Health Care · Pharmaceuticals · BD
Tk466.10
-1.19% today · -2.6% 1Y
Renata PLC (DSE: RENATA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $437.01M.
Over the last twelve months the share price has lost 2.6%, trading between 372.00 and 547.00.
Tweenvest scores Renata PLC across four factors: quality 68/100, value 63/100, growth 22/100, dividend 27/100. Its strongest factor is quality.
RENATA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $437.01M
- Revenue (TTM)
- $366.42M
- P/E
- 19.58
- EPS
- 23.81
- Dividend yield
- 1.18%
- Beta (5Y)
- -0.00
- 52-week high
- Tk547.00
- 52-week low
- Tk372.00
- Avg volume (3M)
- —
- Shares outstanding
- 114.70M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.97 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $269.67 | -1.27% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.19 | -2.08% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.